UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

MicroRNA in pancreatic cancer

Journal of human genetics, 2017-01, Vol.62 (1), p.33-40

2017

Volltextzugriff (PDF)

ZFP36L2 promotes cancer cell aggressiveness and is regulated by antitumor microRNA‐375 in pancreatic ductal adenocarcinoma

Cancer science, 2017-01, Vol.108 (1), p.124-135

2017

Volltextzugriff (PDF)

Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma

International journal of oncology, 2016-12, Vol.49 (6), p.2255-2264

2016

Volltextzugriff (PDF)

Noncoding RNA and colorectal cancer: its epigenetic role

Journal of human genetics, 2017-01, Vol.62 (1), p.41-47

2017

Volltextzugriff (PDF)

Impact of Snail and E-cadherin expression in pancreatic neuroendocrine tumors

Oncology letters, 2017-08, Vol.14 (2), p.1697-1702

2017

Volltextzugriff (PDF)

Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma

Oncotarget, 2017-08, Vol.8 (32), p.53180-53193

2017

Volltextzugriff (PDF)

The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster

Oncotarget, 2017-09, Vol.8 (41), p.70097-70115

2017

Volltextzugriff (PDF)

Expression of Maternal Embryonic Leucine Zipper Kinase (MELK) Correlates to Malignant Potentials in Hepatocellular Carcinoma

Anticancer research, 2016-10, Vol.36 (10), p.5183-5188

2016

Volltextzugriff (PDF)

ZFP 36L2 promotes cancer cell aggressiveness and is regulated by antitumor micro RNA ‐375 in pancreatic ductal adenocarcinoma

Cancer science, 2017-01, Vol.108 (1), p.124-135

2017

Volltextzugriff (PDF)

Examination of proton beam therapy for pancreatic cancer in our department

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2016-08, Vol.16 (4), p.S66-S66

2016

Volltextzugriff (PDF)

Appropriate treatment strategy for IPMN

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2016-08, Vol.16 (4), p.S157-S157

2016

Volltextzugriff (PDF)

F-071 Examination of proton beam therapy for pancreatic cancer in our department

Journal of the Japan Pancreas Society, 2016-07, Vol.31 (3), p.438-439

2016

Volltextzugriff (PDF)

P-247 Appropriate treatment strategy for IPMN

Journal of the Japan Pancreas Society, 2016-07, Vol.31 (3), p.592-592

2016

Volltextzugriff (PDF)

A case of rectal cancer which showed complete response to chemotherapy for para-aortic lymph node metastases remaining after surgery, for which resection of Virchow's lymph node recurrence led to long-term survival

Gan to kagaku ryoho, 2013-09, Vol.40 (9), p.1233

2013

Volltextzugriff (PDF)

Oral formulation of bendamustine hydrochloride for patients with advanced solid tumors; a phase 1 study

Investigational new drugs, 2023-02, Vol.41 (1), p.1-12

2023

Volltextzugriff (PDF)

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

The New England journal of medicine, 2022-02, Vol.386 (5), p.437-448

2022

Volltextzugriff (PDF)

Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE‐826

Cancer science, 2022-11, Vol.113 (11), p.3877-3887

2022

Volltextzugriff (PDF)

Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study

Cancer science, 2022-08, Vol.113 (8), p.2788-2797

2022

Volltextzugriff (PDF)

Lenvatinib plus pembrolizumab in Japanese patients with endometrial cancer: Results from Study 309/KEYNOTE‐775

Cancer science, 2022-10, Vol.113 (10), p.3489-3497

2022

Volltextzugriff (PDF)

Phase 1 dose‐escalation study of single‐agent veliparib in Japanese patients with advanced solid tumors

Cancer science, 2017-09, Vol.108 (9), p.1834-1842

2017

Volltextzugriff (PDF)

Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA)

Journal of clinical oncology, 2021-11, Vol.39 (33), p.3671-3681

2021

Volltextzugriff (PDF)

237 InnovaTV 301/ENGOT-Cx12/GOG-3057: a global, randomized, open-label, phase 3 study of tisotumab vedotin versus investigator’s choice of chemotherapy in 2L Or 3L recurrent or metastatic cervical cancer

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A4-A5

2024

Volltextzugriff (PDF)

Abstract CT124: Evaluation of rucaparib in Japanese patients (pts) with a previously treated advanced solid tumor

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT124-CT124

2021

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(38)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Oncology
(17)
Humans
(16)
Female
(13)
Chemotherapy
(11)
Cancer Therapies
(9)
Tumors
(8)
Middle Aged
(7)
Original
(7)
Patients
(7)
Aged
(6)
Cancer
(6)
Male
(6)
Medical Prognosis
(6)
Metastasis
(6)
Adult
(5)
Aged, 80 And Over
(5)
Paclitaxel
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MicroRNA in pancreatic cancer

ZFP36L2 promotes cancer cell aggressiveness and is regulated by antitumor microRNA‐375 in pancreatic ductal adenocarcinoma

Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma

Noncoding RNA and colorectal cancer: its epigenetic role

Impact of Snail and E-cadherin expression in pancreatic neuroendocrine tumors

Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma

The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster

Expression of Maternal Embryonic Leucine Zipper Kinase (MELK) Correlates to Malignant Potentials in Hepatocellular Carcinoma

ZFP 36L2 promotes cancer cell aggressiveness and is regulated by antitumor micro RNA ‐375 in pancreatic ductal adenocarcinoma

Examination of proton beam therapy for pancreatic cancer in our department

Appropriate treatment strategy for IPMN

F-071 Examination of proton beam therapy for pancreatic cancer in our department

P-247 Appropriate treatment strategy for IPMN

A case of rectal cancer which showed complete response to chemotherapy for para-aortic lymph node metastases remaining after surgery, for which resection of Virchow's lymph node recurrence led to long-term survival

Oral formulation of bendamustine hydrochloride for patients with advanced solid tumors; a phase 1 study

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial

Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study

Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE‐826

Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study

Lenvatinib plus pembrolizumab in Japanese patients with endometrial cancer: Results from Study 309/KEYNOTE‐775

Phase 1 dose‐escalation study of single‐agent veliparib in Japanese patients with advanced solid tumors

Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA)

237 InnovaTV 301/ENGOT-Cx12/GOG-3057: a global, randomized, open-label, phase 3 study of tisotumab vedotin versus investigator’s choice of chemotherapy in 2L Or 3L recurrent or metastatic cervical cancer

Abstract CT124: Evaluation of rucaparib in Japanese patients (pts) with a previously treated advanced solid tumor

Suchergebnisse filtern